14 million short #$%$ are a powerful force. They have the influence to shove a little pup like Biocryst all around the map. C'mon Stoney, announce a major stockpiling order and trap them good and proper.
Haha. Jim Cramer is at it again. Of course, he didn't like BCRX when it was $3, so I guess his loyal followers missed out on 300% + appreciation.
Hey Husky. What do these numbers mean exactly?
Take 3/13 for instance. Are you saying that 391K shares were purchased by longs and 875K shares were shorted? So short interest grew by the difference on that day? I can't quite get my head around this.
Shionogi (spelling?) does not have the rights to sell P outside of Japan and SK.
I'm sure they could get the 'knock-off' Chinese version though.
I posted a comment about this climb in short interest last night (in a thread started by M-Dad. Somehow it was deleted. Please please announce stockpiling order and trap these shorty bizztards like they deserve.
12 million shorts exert a lot of influence. Sham downgrades. The B of A Merrill guy has been a #$%$ regarding BCRX for ever (and completely wrong so far on his target prices). I hate that those bloddy shorts are able to get out of their positions for no (or next to no) loss.
I hope that Stoney gets to announce a decent Rapivab order from the Govt, and then the shorts that are left (an hopefully most of the greedy pigs stay short) get fried. Otherwise it's a long wait unto HAE results.
"And should have big pharma hungry for m & a kicking tires. "
Which, of course, they might well be even as we type.
Maybe i was waxing a little rhetorical but this has drifted back down from the $14 mark even though everything has gone our way, and this isn't much in the wings to make a dramatic move till HAE at the very end of the year (with the exception of Rapivab stockpiling which I thought would happen quickly but hasn't and now i'm not going to hold my breath).
I still think that the shorts have had it lucky – for them to get out at under ten dollars like this morning and many not lose a dime. I would count them very lucky
So sad. Not surprising I guess after the much anticipated stockpiling order never came. There are so few catalysts in the near future, that I reckon we could hover around ten dollar for months.
I read the PR as the one drug is starting now and ours is on deck ... probably waiting for this safety trial to be done first
Efficacy! This one would be on actual Ebola infected peoples (as opposed to healthy subjects - just testing for safety).
"... what happened to the 30,000 doses on the trucks"
I think that 30,000 number was "available doses" – lets not get too excited about that just yet.
Great summary dog. Enthusiastic thumbs up.
Shorties have made hay on this stock over the years as it always pulls back after seasons of hype (SARS, Swine Flu etc) and I think they were jumping in for another pay-off with Ebola (which they knew would inevitably drop out of the news... and it has). However so much else happened in the meantime (including a drug approval!! and fast track for HAE). Ebola hype waning has stopped us going to $15-20 on all the other news but shorties have been trapped. If a stockpiling order comes soon then they are plucked. Their last hope is very conservative guidance on Rapivab sales during the CC (but I still think they will see only a dollar or so relief on the share price at most).
PS: I wish we would see something on a new molecule (other than next gen HAE stuff).
Is BCRX on a Dec 31 fiscal calendar? Rapivab was approved 2 days before Christmas. I'd say that there were no sales recorded in Q4. Hopefully they will give us some guidance on stocks of Rapi moving out the door. 30K seems a bit high to me (for a drug that was approved halfway through flu season without the benefit of advanced marketing).
Cheers map. I listened too. Very business like. I took a couple of phone calls during so missed a few bits. Did Stoney actually say SNS possibility of $1 billion?
I can't get my head around the way Biocryst trades anymore. Everything that we were hoping to happen over the last few months did (with possible exception of an immediate stockpiling order for "P," which, by the way, is still on the cards). Somehow we keep testing the $10 mark.